People risk management and agile operational resilience
COVID-19 required businesses to refocus on their most important asset: Their people. Learn 10 essential elements of a successful people risk management solution.
Keep up to date on recent Everbridge news, events, and content, including from our recent thought leadership events and articles.
Below are reports* † in which we’ve received recognition. In addition to those published here, we are also excited to be included in:
COVID-19 required businesses to refocus on their most important asset: Their people. Learn 10 essential elements of a successful people risk management solution.
COVID brought to light the significance of a thorough and prepared operational resilience strategy to maintain business functions through unprecedented crises.
Watch this on-demand webinar to learn how to enable resilient IT Operations.
The 2022 Winter Olympics will be held in Beijing and nearby areas from February 4 to 20, with the Paralympics following from March 4 to 13.
Download this whitepaper to learn the 4 steps for implementing an effective DevSecOps infrastructure.
Learn how Guilford leverages Everbridge for sending situational reports to key stakeholders, achieving 26,000 Spanish and English notification opt-ins, and pre-scripted mess
*Forrester reports are available to Forrester subscribers or for purchase.
†Gartner reports are available for Gartner subscribers only
†GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
†Gartner® does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.